About Ambagon Therapeutics
Ambagon Therapeutics is a private company based in Eindhoven, Netherlands, incorporated in 2020 in Delaware. It has reported $55,399,994 raised in three offerings on Form D since August 2020. Its chief executive is Christian Ottmann.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | Feb 7, 2025 | $5,000,000of $12.0M target | 4 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Jan 5, 2022 | Jan 19, 2022amended Jun 1, 2022 | $44,999,996of $84.9M target | 9 | $4.9M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 7, 2021 | Aug 3, 2020amended Dec 22, 2021 | $5,399,998fully sold | 8 | $674K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Total, three offerings | $55,399,994 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ambagon Therapeutics's Form D filed Feb 7, 2025.
MM
Melissa McCracken
Partner, Nextech Invest and director
First appears on the Form D that Ambagon Therapeutics filed on January 19, 2022; on 3 of its 6 filings.
JS
Josh Seidenfeld
Executive officer
First appears on the amended Form D that Ambagon Therapeutics filed on August 20, 2021; on 5 of its 6 filings.

Christian Ottmann
Co-Founder & Chief Executive Officer
On every Form D that Ambagon Therapeutics has filed: 6 filings, from Aug 3, 2020 to Feb 7, 2025.
Earlier filings also listed
- Scott Clarke · chief executive officer and directorLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 4 of its 6 filings.
- Roel Bulthuis · directorLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 5 of its 6 filings.
- Peter Dudek · directorLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 5 of its 6 filings.
- Nancy Pryer · executive officerLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 4 of its 6 filings.
- Michelle Arkin · directorLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 5 of its 6 filings.
- Margarita Chavez · directorLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 5 of its 6 filings.
- Janwillem Naesens · directorLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 5 of its 6 filings.
- Bryan Miller · executive officerLast listed on the amended Form D that Ambagon Therapeutics filed on June 1, 2022; on 4 of its 6 filings.
